Sort
261,768 grants matching “gene therapy”
Normal And Pathologic Mechanisms Of Inflammation, Innate And Acquired Immunity
$1,632,889Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
Host factors contributing to susceptibility to COVID-19 disease
$1,632,832Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$1,632,775Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2017 · CA
Targets for Therapy for Carcinomas of the Lung
$1,632,700Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2013 · CA
Boston Area Diabetes Endocrinology Research Center
$1,632,525Joseph Avruch · Massachusetts General Hospital · P30 · FY2006 · DK
CAM Center for Epigenetic Regulation of Inflammation
$1,632,449Prakash S. Nagarkatti · University Of South Carolina At Columbia · P01 · FY2017 · AT
Clinical Outcomes in Aicardi Goutières Syndrome
$1,632,098Adeline Lucie Vanderver · Children'S Hosp Of Philadelphia · U01 · FY2021 · NS
Mental Retardation &Developmental Disabilities Research
$1,632,070Children'S Hospital Boston · P30 · FY2004 · HD
Activities Of Chemokines In Health and Disease
$1,631,747Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,631,732Daniel Woo · University Of Cincinnati · R01 · FY2011 · NS
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease
$1,631,705Allan I Levey · Emory University · U01 · FY2017 · AG
Immune modulation of radiation therapy with Flt3 ligand
$1,631,702Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2021 · CA
Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases
$1,630,994Daniel Kastner · National Human Genome Research Institute · ZIA · FY2024 · HG
PROJECT 2: HEREDITARY TYROSINEMIA TYPE 1 (HT1)
$1,630,863William H. Peranteau · Children'S Hosp Of Philadelphia · U19 · FY2024 · NS
Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users
$1,630,854Melanie Maria Ott · J. David Gladstone Institutes · R01 · FY2023 · DA
Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency
$1,630,493Dennis Durand Hickstein · Clinical Sciences · Z01 · FY2007 · CA
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
$1,630,446Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
$1,630,446Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2016 · CA
Collaborative African Genomics Network (CAFGEN)
$1,630,165Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2014 · AI
Role of Pluripotency Factors in Embryonic Stem Cells, Development and Disease
$1,630,161Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Development of a Clinical Hemoglobin Modulator
$1,630,002Susan P Perrine · Phoenicia Biosciences, Inc. · R33 · FY2022 · HL
Diagnosis, Pathophysiology And Molecular Biology Of Pheochromocytoma
$1,629,982Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
UCLA SPOTRIAS Center Application
$1,629,942University Of California Los Angeles · P50 · FY2005 · NS
Protein Expression Facility
$1,629,843Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Development of new antibody-based cancer therapies
$1,629,751Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA